Speciality Medicines Limited (BOM:544738)
205.40
+34.20 (19.98%)
At close: Apr 16, 2026
Speciality Medicines Market Cap
Speciality Medicines has a market cap or net worth of 1.8 billion as of April 16, 2026.
Market Cap
1.80B
Enterprise Value
1.85B
Revenue
582.71M
Ranking
n/a
PE Ratio
18.37
Stock Price
205.40
Market Cap Chart
Since March 30, 2026, Speciality Medicines's market cap has increased from 1.11B to 1.80B, an increase of 63.15%. That is a compound annual growth rate of 7,068,941.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 1.50B | 5.00% |
| Apr 13, 2026 | 1.43B | 4.99% |
| Apr 10, 2026 | 1.36B | 4.97% |
| Apr 9, 2026 | 1.30B | 4.97% |
| Apr 8, 2026 | 1.24B | 4.99% |
| Apr 7, 2026 | 1.18B | 4.84% |
| Apr 6, 2026 | 1.13B | 1.03% |
| Apr 2, 2026 | 1.11B | 0.60% |
| Apr 1, 2026 | 1.11B | 0.08% |
| Mar 30, 2026 | 1.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanjivani Paranteral | 2.05B |
| Oxygenta Pharmaceutical | 1.96B |
| Aayush Wellness | 1.69B |
| Astonea Labs | 1.63B |
| Parnax Lab | 1.61B |
| Bilcare | 1.45B |
| Coral Laboratories | 1.44B |
| Bal Pharma | 1.19B |